• One-way sensitivity analyses identified key variables and these were:
• Cost of 'molecular autopsy', when 3 family members or less had predictive genetic testing the 'molecular autopsy' strategy became costeffective rather than cost-saving (Table 1) • Costs were from a third-party payer perspective • Effectiveness measured in life-years gained (LYG)
• One-way sensitivity analyses were conducted over the plausible ranges of all variables (Table 1) • 'Molecular autopsy' cost was divided by number of family members who would undergo predictive genetic testing. In the base case, 4 relatives (1-8)
• Genetic testing was set at $3500/€ with a pick-up rate of 35%
• It was assumed the disease in the family was LQTS
• Figure 1 
